HRT Financial’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIPO.WS
CAC
SPC
KL
LCG
SRF
CCA
HRT Financial's HIPO.WS Position: Q4 2022 in Review
HRT Financial sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q4 2022, closing a stake of 13,876 shares — an estimated $2K sold.
HRT Financial first reported a position in HIPO.WS in Q3 2021 and held it in 5 quarters. The position peaked at $17K in Q3 2021. 18 funds tracked by Wall St. Rank hold HIPO.WS as of Q4 2022.
- HRT Financial reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q4 2022 after selling out during the quarter.
- HRT Financial sold 13,876 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q4 2022, an estimated $2K.
- HRT Financial first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q3 2021 and held it in 5 quarters.
- HRT Financial's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $17K in Q3 2021.
- 18 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q4 2022.
Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.